See the exclusive preview of the new QIAGEN Clinical Insight Interpret Translational...

Discover a simpler and faster approach to implementing clinical NGS...

Despite rapid cost reductions in sequencing technologies and an ever-increasing...

For the past two decades, the paradigm in the field has been “one biomarker, one drug,”...

For NGS cancer testing, keeping pace with new discoveries is a serious bottleneck....

Speaker: Sheryl Elkin, CSO, N-of-One.a QIAGEN Company Interested in learning more?...

The integration of next-generation sequencing (NGS) into the diagnostic process for...

BRCA1/BRCA2 genes represent the best examples for our current understanding of the...